Healthequity, Inc. (HQY) Stock Analysis and Metrics

Healthequity

NASDAQ: HQY

$94.66 ▲ +0.33 (+0.35%)

At close: Jul 24, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap7.96 Bn

P/E34.51

P/S5.95

Div. Yield0.00

Total Debt (Qtr)942.66 Mn

Revenue Growth (1y) (Qtr)7.19

Add ratio to table…

About

Healthequity, Inc. provides technology enabled services that help consumers manage healthcare saving, spending, and investing decisions. The company administers tax advantaged health savings accounts (HSAs) and other consumer directed benefits such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA continuation coverage, and commuter programs. Through its platform, Healthequity offers payment processing, personalized benefit information, a healthcare marketplace, and investment advisory services to grow members tax advantaged savings.

Healthequity generates revenue from three primary sources: service, custodial, and interchange. Service revenue consists of fees paid by employer clients, network partners, and account holders for administration of HSAs and other CDBs, as well as earnings from invested HSA assets and the marketplace. Custodial revenue is derived from fees on HSA cash held by depository partners, including insurance company affiliated Enhanced Rates accounts and bank affiliated Basic Rates accounts, plus fees on client held funds deposited with those partners. Interchange revenue comes from merchant fees on payments made using the company's physical and virtual payment cards.

Healthequity holds a leading position in the HSA industry, ranking as the largest provider by number of accounts and the second largest by HSA assets as of June 2025, according to the 2025 Midyear Devenir HSA Research Report. The company's HSA asset market share grew from 4% in December 2010 to 20% in June 2025. Key competitors include traditional banks, insurance companies, and financial services firms such as Fidelity Investments, UnitedHealth Group's Optum division, and Webster Bank, as well as various health insurance carriers, HR consultants, payroll providers, and specialized third party administrators. Competitive advantages stem from a service driven culture, broad product suite, deep ecosystem connectivity with more than 200 network partners, and a proprietary cloud based technology platform that integrates eligibility, claims processing, payment, and investment functionalities.

The company serves a diverse customer base that includes employer clients who offer HSAs and other consumer directed benefits to their workers, benefits brokers and advisors who recommend its solutions, network partners such as health plans, benefits administrators, and retirement plan recordkeepers that integrate its platform, and individual account holders (members) who use the accounts to save, spend, and invest for healthcare expenses. No specific customer names are disclosed in the filing.

Investment Thesis

▲ Bull case

HealthEquity is positioned to benefit from a structural shift in healthcare affordability that is expanding the total addressable market beyond traditional HSA growth, with the company already outperforming industry benchmarks. Management highlighted that rising healthcare costs are driving employers to shift more financial responsibility to consumers, creating durable demand for HSAs as a tax-advantaged savings vehicle. This trend is reinforced by the company’s Q1 FY27 results, where total HSA assets grew 19% and new HSAs from sales increased 15%, introducing 172,000 new accounts. Crucially, HealthEquity bent the growth curve with 8% total HSA account growth, surpassing Devenir’s reported market growth of 6% for calendar year 2025, indicating meaningful share gains in a fragmented industry. The company’s ability to outpace the market despite macroeconomic headwinds suggests its platform differentiation—particularly in digital engagement and AI-driven service efficiency—is resonating with employers seeking scalable solutions to control healthcare costs. This structural tailwind is not temporary; it reflects a long-term reconfiguration of how healthcare is financed, with HSAs becoming central to employee benefits strategy. As more employers adopt high-deductible health plans and seek tools to improve HSA utilization, HealthEquity’s integrated platform—which combines accounts, assets, payments, investing, and marketplace offerings—creates switching costs that deepen client relationships and reduce reliance on volatile new account flows. The company’s focus on lifetime value per member, rather than just account acquisition, positions it to capture expanding revenue streams as existing accounts mature and contribute more through higher contributions, investment activity, and marketplace engagement. This evolution beyond administration into a healthcare financial operating system is a key driver of durable, compounding growth that the market may be underestimating in its current valuation.
The company’s AI and automation initiatives are unlocking scalable operational efficiencies that are improving margins while simultaneously enhancing member experience and engagement, creating a self-reinforcing flywheel. In Q1 FY27, HealthEquity reported adjusted EBITDA margin expansion to 46% from 42% in the prior year, driven by service cost improvements and revenue growth. AI-driven tools reduced manual handling of member and client service emails by 25%, with certain workflows like card servicing and claims inquiries seeing over 90% reduction in manual effort and up to 50% faster processing times. These efficiencies translated into more than 50,000 fewer card-related service center contacts and a nearly 90% decline in fraud costs year-over-year. Importantly, management emphasized that these gains are not isolated improvements but part of a broader strategy where AI acts as an operational amplifier—reducing cost to serve while increasing self-service adoption, which in turn drives deeper platform engagement. Over two-thirds of marketplace transactions now occur via the mobile app, and mobile monthly active usage increased 90% year-over-year, indicating that digital engagement is becoming a primary channel for member interaction. This shift not only lowers operational costs but also increases exposure to high-margin offerings like the Mark marketplace and investment services, where engaged members demonstrate higher average contributions, larger balances, and greater spending over time. The company’s investment in AI is not merely a cost-saving exercise; it is a strategic enabler of the flywheel effect, where improved service quality fuels engagement, which drives revenue growth from higher-value activities, which then funds further innovation. As AI tools mature and scale across additional journeys—such as back-office claims automation and client integrations—the margin expansion potential remains significant, with management noting they are still in the early innings of realizing these benefits. This operational leverage, combined with growing revenue durability from maturing accounts, supports the raised fiscal 2027 guidance and suggests the market may not be fully appreciating the sustainability of margin expansion beyond cyclical factors.
The Mark marketplace represents an underappreciated, high-margin revenue stream with significant runway for growth, driven by member demand for health and wellness products that align with existing HSA spending patterns. Although marketplace revenue is not yet broken out separately and remains embedded in service revenue, management provided compelling insights into its traction and economics. Over 10,000+ members are actively transacting in Mark, with week-on-week growth observed even without dedicated marketing spend, indicating organic adoption fueled by product relevance. The most active program—metabolic health through access to weight loss (GLP-1 agonists)—generates an administrative fee of $90–$100 per participating member per month, while newer offerings like men’s health (TRT) exceed $50 per member per month. These economics imply meaningful revenue potential even at modest adoption rates; for example, 10,000 members in the GLP program alone could generate over $10 million in annualized revenue. Management emphasized that Mark is being built around what members are already spending dollars on—curating products and services informed by actual HSA expenditure data—rather than offering generic reimbursable items. This demand-driven approach reduces customer acquisition cost and increases retention, as members derive tangible value from managing conditions like metabolic health, men’s wellness, and diagnostics through their HSAs. The recent expansion into diagnostics and men’s health saw rapid uptake without marketing rhythm, underscoring strong product-market fit. Furthermore, Mark transactions are inherently high-margin, with no cost of acquisition or significant cost to serve, allowing most revenue to flow directly to the bottom line. As the platform scales and integrates more deeply with the mobile app—where two-thirds of marketplace transactions already occur—the flywheel effect intensifies: engaged members are more likely to invest, contribute more, and spend via the marketplace, increasing lifetime value. Given that less than 10% of HSAs industry-wide currently use the full tax benefits of investing, and marketplace adoption is still nascent, Mark represents a multi-year opportunity to monetize engagement in a way that is both defensible and complementary to the core custodial business, with the market likely underestimating its long-term contribution to revenue diversification and margin profile.

HealthEquity is positioned to benefit from a structural shift in healthcare affordability that is expanding the total addressable market beyond traditional HSA growth, with the company already outperforming industry benchmarks. Management highlighted that rising healthcare costs are driving employers to shift more financial responsibility to consumers, creating durable demand for HSAs as a tax-advantaged savings vehicle. This trend is reinforced by the company’s Q1 FY27 results, where total HSA assets grew 19% and new HSAs from sales increased 15%, introducing 172,000 new accounts. Crucially, HealthEquity bent the growth curve with 8% total HSA account growth, surpassing Devenir’s reported market growth of 6% for calendar year 2025, indicating meaningful share gains in a fragmented industry. The company’s ability to outpace the market despite macroeconomic headwinds suggests its platform differentiation—particularly in digital engagement and AI-driven service efficiency—is resonating with employers seeking scalable solutions to control healthcare costs. This structural tailwind is not temporary; it reflects a long-term reconfiguration of how healthcare is financed, with HSAs becoming central to employee benefits strategy. As more employers adopt high-deductible health plans and seek tools to improve HSA utilization, HealthEquity’s integrated platform—which combines accounts, assets, payments, investing, and marketplace offerings—creates switching costs that deepen client relationships and reduce reliance on volatile new account flows. The company’s focus on lifetime value per member, rather than just account acquisition, positions it to capture expanding revenue streams as existing accounts mature and contribute more through higher contributions, investment activity, and marketplace engagement. This evolution beyond administration into a healthcare financial operating system is a key driver of durable, compounding growth that the market may be underestimating in its current valuation.
The company’s AI and automation initiatives are unlocking scalable operational efficiencies that are improving margins while simultaneously enhancing member experience and engagement, creating a self-reinforcing flywheel. In Q1 FY27, HealthEquity reported adjusted EBITDA margin expansion to 46% from 42% in the prior year, driven by service cost improvements and revenue growth. AI-driven tools reduced manual handling of member and client service emails by 25%, with certain workflows like card servicing and claims inquiries seeing over 90% reduction in manual effort and up to 50% faster processing times. These efficiencies translated into more than 50,000 fewer card-related service center contacts and a nearly 90% decline in fraud costs year-over-year. Importantly, management emphasized that these gains are not isolated improvements but part of a broader strategy where AI acts as an operational amplifier—reducing cost to serve while increasing self-service adoption, which in turn drives deeper platform engagement. Over two-thirds of marketplace transactions now occur via the mobile app, and mobile monthly active usage increased 90% year-over-year, indicating that digital engagement is becoming a primary channel for member interaction. This shift not only lowers operational costs but also increases exposure to high-margin offerings like the Mark marketplace and investment services, where engaged members demonstrate higher average contributions, larger balances, and greater spending over time. The company’s investment in AI is not merely a cost-saving exercise; it is a strategic enabler of the flywheel effect, where improved service quality fuels engagement, which drives revenue growth from higher-value activities, which then funds further innovation. As AI tools mature and scale across additional journeys—such as back-office claims automation and client integrations—the margin expansion potential remains significant, with management noting they are still in the early innings of realizing these benefits. This operational leverage, combined with growing revenue durability from maturing accounts, supports the raised fiscal 2027 guidance and suggests the market may not be fully appreciating the sustainability of margin expansion beyond cyclical factors.
The Mark marketplace represents an underappreciated, high-margin revenue stream with significant runway for growth, driven by member demand for health and wellness products that align with existing HSA spending patterns. Although marketplace revenue is not yet broken out separately and remains embedded in service revenue, management provided compelling insights into its traction and economics. Over 10,000+ members are actively transacting in Mark, with week-on-week growth observed even without dedicated marketing spend, indicating organic adoption fueled by product relevance. The most active program—metabolic health through access to weight loss (GLP-1 agonists)—generates an administrative fee of $90–$100 per participating member per month, while newer offerings like men’s health (TRT) exceed $50 per member per month. These economics imply meaningful revenue potential even at modest adoption rates; for example, 10,000 members in the GLP program alone could generate over $10 million in annualized revenue. Management emphasized that Mark is being built around what members are already spending dollars on—curating products and services informed by actual HSA expenditure data—rather than offering generic reimbursable items. This demand-driven approach reduces customer acquisition cost and increases retention, as members derive tangible value from managing conditions like metabolic health, men’s wellness, and diagnostics through their HSAs. The recent expansion into diagnostics and men’s health saw rapid uptake without marketing rhythm, underscoring strong product-market fit. Furthermore, Mark transactions are inherently high-margin, with no cost of acquisition or significant cost to serve, allowing most revenue to flow directly to the bottom line. As the platform scales and integrates more deeply with the mobile app—where two-thirds of marketplace transactions already occur—the flywheel effect intensifies: engaged members are more likely to invest, contribute more, and spend via the marketplace, increasing lifetime value. Given that less than 10% of HSAs industry-wide currently use the full tax benefits of investing, and marketplace adoption is still nascent, Mark represents a multi-year opportunity to monetize engagement in a way that is both defensible and complementary to the core custodial business, with the market likely underestimating its long-term contribution to revenue diversification and margin profile.

▼ Bear case

HealthEquity’s reported financial strength may be overstated due to transient and non-recurring benefits that are not sustainable, particularly in custodial revenue and service cost improvements, creating risk to future margin expansion. While the company highlighted a record $174 million in custodial revenue—up 11% year-over-year—this growth was partially driven by a one-time breakage fee from a depository partner exiting a custodial cash contract early, which boosted the annualized yield on HSA cash to 3.84%. Excluding this item, the yield would have been 3.78%, suggesting underlying cash yield performance is more modest than presented. Additionally, the improvement in service costs—down approximately $6 million year-over-year—was influenced by a $2 million reduction in medical claim utilization for employees, which management acknowledged as likely seasonal and not indicative of a permanent trend, noting they pushed this benefit back into the forecast as conservative. Fraud reimbursements also declined sharply from $3.2 million to $300 thousand, but this reflects lapping a high prior-period base rather than a structural improvement in fraud prevention that can be replicated at scale. These factors combine to create a flattering Q1 FY27 performance that may not be repeatable, especially as the non-recurring yield benefit laps and employee healthcare utilization normalizes. The company’s forward treasury contracts, which lock in approximately 3.9% on $3.5 billion of maturities across FY27–FY29, further limit upside potential in custodial yield if market rates remain elevated, while leaving HealthEquity exposed to downside risk if rates fall. With adjusted EBITDA margin guidance for FY27 implying only modest expansion from the Q1 level, the market may be overestimating the durability of recent margin gains, particularly if core revenue growth fails to accelerate sufficiently to offset these transient benefits.
The Mark marketplace, while touted as a strategic innovation, remains immaterial to overall revenue and faces significant hurdles to scalability that management did not adequately address, including limited member engagement depth, uncertain retention, and lack of clear monetization pathways beyond early-adopter programs. Despite highlighting over 10,000+ members using Mark, the company refused to break out marketplace revenue, acknowledging it will be “a while before it is material relative to our overall revenue” and that it currently flows into service revenue—a segment that grew only 3% year-over-year to $123 million. This suggests the marketplace is contributing immaterially to top-line growth, even as management cites high per-member economics (e.g., $90–$100/month for GLP, $50+/month for TRT). The disconnect between claimed unit economics and negligible revenue impact implies either low activation rates, high churn, or limited member spending conversion—issues not resolved in the discussion. Management admitted it is “still very early” in understanding cohort performance, particularly for metabolic health, and conceded they are “literally only months into this cohort” to assess true retention and program duration. Without evidence of sustained engagement beyond initial sign-ups, the marketplace risks becoming a costly experiment in product diversification rather than a profit driver. Furthermore, the reliance on organic growth without marketing spend—while presented as a strength—may limit scalability, as employers and members may not adopt new wellness offerings without clear communication or integration into benefits design. The marketplace also lacks network effects; unlike a true platform, it does not appear to create increasing value as more members join, and there is no indication it is driving new account acquisition or reducing service costs meaningfully. With competitors potentially launching similar offerings and no proprietary moat evident, Mark’s long-term contribution to lifetime value remains speculative, and the market may be overestimating its strategic importance based on early, anecdotal traction.

HealthEquity’s reported financial strength may be overstated due to transient and non-recurring benefits that are not sustainable, particularly in custodial revenue and service cost improvements, creating risk to future margin expansion. While the company highlighted a record $174 million in custodial revenue—up 11% year-over-year—this growth was partially driven by a one-time breakage fee from a depository partner exiting a custodial cash contract early, which boosted the annualized yield on HSA cash to 3.84%. Excluding this item, the yield would have been 3.78%, suggesting underlying cash yield performance is more modest than presented. Additionally, the improvement in service costs—down approximately $6 million year-over-year—was influenced by a $2 million reduction in medical claim utilization for employees, which management acknowledged as likely seasonal and not indicative of a permanent trend, noting they pushed this benefit back into the forecast as conservative. Fraud reimbursements also declined sharply from $3.2 million to $300 thousand, but this reflects lapping a high prior-period base rather than a structural improvement in fraud prevention that can be replicated at scale. These factors combine to create a flattering Q1 FY27 performance that may not be repeatable, especially as the non-recurring yield benefit laps and employee healthcare utilization normalizes. The company’s forward treasury contracts, which lock in approximately 3.9% on $3.5 billion of maturities across FY27–FY29, further limit upside potential in custodial yield if market rates remain elevated, while leaving HealthEquity exposed to downside risk if rates fall. With adjusted EBITDA margin guidance for FY27 implying only modest expansion from the Q1 level, the market may be overestimating the durability of recent margin gains, particularly if core revenue growth fails to accelerate sufficiently to offset these transient benefits.
The Mark marketplace, while touted as a strategic innovation, remains immaterial to overall revenue and faces significant hurdles to scalability that management did not adequately address, including limited member engagement depth, uncertain retention, and lack of clear monetization pathways beyond early-adopter programs. Despite highlighting over 10,000+ members using Mark, the company refused to break out marketplace revenue, acknowledging it will be “a while before it is material relative to our overall revenue” and that it currently flows into service revenue—a segment that grew only 3% year-over-year to $123 million. This suggests the marketplace is contributing immaterially to top-line growth, even as management cites high per-member economics (e.g., $90–$100/month for GLP, $50+/month for TRT). The disconnect between claimed unit economics and negligible revenue impact implies either low activation rates, high churn, or limited member spending conversion—issues not resolved in the discussion. Management admitted it is “still very early” in understanding cohort performance, particularly for metabolic health, and conceded they are “literally only months into this cohort” to assess true retention and program duration. Without evidence of sustained engagement beyond initial sign-ups, the marketplace risks becoming a costly experiment in product diversification rather than a profit driver. Furthermore, the reliance on organic growth without marketing spend—while presented as a strength—may limit scalability, as employers and members may not adopt new wellness offerings without clear communication or integration into benefits design. The marketplace also lacks network effects; unlike a true platform, it does not appear to create increasing value as more members join, and there is no indication it is driving new account acquisition or reducing service costs meaningfully. With competitors potentially launching similar offerings and no proprietary moat evident, Mark’s long-term contribution to lifetime value remains speculative, and the market may be overestimating its strategic importance based on early, anecdotal traction.

Peer Comparison

Companies in the Health Information Services

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	VEEV	Veeva Systems Inc	29.34 Bn	31.16	8.84	-
2	BTSG	BrightSpring Health Services, Inc.	13.49 Bn	46.18	0.99	2.50 Bn
3	HQY	Healthequity, Inc.	7.96 Bn	34.51	5.95	0.94 Bn
4	TXG	10x Genomics, Inc.	6.17 Bn	-272.14	9.65	-
5	HNGE	Hinge Health, Inc.	6.02 Bn	-11.77	9.31	-
6	MMED	MiniMed Group, Inc.	4.19 Bn	-8.88	1.38	-
7	WAY	Waystar Holding Corp.	4.14 Bn	32.80	3.58	1.47 Bn
8	DOCS	Doximity, Inc.	3.82 Bn	19.51	5.93	-

Research Tools

Developers

About

Investment Thesis

Product and Service Breakdown of Revenue (2026)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Product and Service Breakdown of Revenue (2026)

Peer Comparison

Create an account

Sign In

Reset Password